Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards InheRET $2M SBTT Grant to Improve Inherited Disease Detection

NEW YORK – University of Michigan spinout InheRET said on Thursday that it has received a $2 million Small Business Technology Transfer grant from the National Cancer Institute to expand its Inherited Risk Evaluation Tool (InheRET) to identify patients at risk for hereditary disease.

Ann Arbor, Michigan-based InheRET will use the two-year grant, which was awarded Sept. 10, to further improve the platform, increase integration with electronic health records, and increase its workforce and end userbase.

InheRET said the platform provides a personalized medicine approach to curb barriers that patients and clinicians may face for prevention of and early detection of hereditary disease. The platform identifies patients at increased risk for hereditary cancers and offers next-step recommendations and tailored educational resources for users.

InheRET noted that its cancer risk evaluation has been in pilot testing at Michigan Medicine, with more than 1,000 patients having completed the study. More than 80 percent of patients who began the program completed it. Among the primary care patients in the pilot study, 30 percent were identified as meeting criteria for additional genetic risk evaluation related to hereditary or familiar cancer syndromes.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.